R&D and Manufacturing of Characteristic API

Nanjing Vcare's featured API business conducts process and quality studies, production validation, stability studies and registration and approval in strict accordance with regulatory registration requirements, and supports the association of the drug product plant. Our R & D center has passed the on-site inspection on R & D of CFDA for many times with zero defects. Tianshu Pharmaceutical Co., Ltd., a subordinate production base, has built an API production workshop with a built-up area of 2000 ㎡, including a non-cytotoxic tumor line and a common line, totaling 34 500L-3000L reactors of various specifications, with a capacity of about 55m ³; the factory buildings and facilities have been designed and constructed in strict accordance with the requirements of FDA and cGMP, meeting the quality and registration requirements of high-end customers.